Pain Relief Patches

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin is prohibited due to the potential for irritation and adverse effects.

• Concurrent use with a heating pad is contraindicated as it may increase the risk of burns or skin damage.

• Individuals with known allergies to any ingredients in this product should not use it to prevent allergic reactions.

Additionally, avoid contact with eyes, mucous membranes, or rashes, and do not apply tightly bandaged. The simultaneous use of other topical analgesics is also contraindicated to avoid potential interactions and increased risk of side effects.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a known allergy to aspirin or salicylates, as this product may provoke an allergic reaction in susceptible individuals.

It is imperative to exercise caution when applying this product. It should not be used on wounds or damaged skin, nor should it be combined with a heating pad, as this may exacerbate adverse effects. Additionally, patients should be informed to avoid use if they are allergic to any of the product's ingredients.

Patients must be instructed to discontinue use and seek medical attention if they experience any rash, itching, or excessive skin irritation. Furthermore, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, patients should contact their healthcare provider for further evaluation.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. Individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In clinical practice, patients are instructed to discontinue use and seek medical advice if they experience any of the following symptoms: rash, itching, or excessive skin irritation. Additionally, if the condition being treated worsens or if symptoms persist for more than 7 days, or if they resolve and then recur within a few days, it is essential to consult a healthcare provider for further evaluation and management.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should be evaluated by a physician prior to use. It is crucial to keep used patches out of reach of children and pets, as they may still contain the drug product, which can lead to serious adverse effects if chewed or ingested. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended. Proper disposal of used patches is essential to prevent accidental exposure.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be advised against using this product if they are allergic to any of its ingredients. The product should only be used as directed, and any adverse reactions such as rash, itching, or excessive skin irritation warrant immediate consultation with a healthcare provider.

It is important to keep this product out of reach of children, and in the event of accidental ingestion, medical assistance should be sought or a Poison Control Center contacted promptly. Additionally, the use of this product in children under 12 years of age requires consultation with a physician.

Due to the lack of specific data regarding the safety of this product during pregnancy, healthcare professionals should weigh the potential risks and benefits before recommending its use to pregnant patients or women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while no specific overdosage information is provided, healthcare professionals should be prepared to act swiftly and effectively in the event of an overdose, ensuring that appropriate measures are taken to safeguard patient health.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed of the potential for allergic reactions and advised not to use the product if they are allergic to any of its ingredients. They should be instructed to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be made aware that they should stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using the product, patients must be reminded to follow the directions provided and to avoid contact with eyes, mucous membranes, or rashes. They should also be cautioned against bandaging the area tightly and using the product simultaneously with other topical analgesics.

Finally, healthcare providers should emphasize the importance of proper disposal of used patches, ensuring that they are kept out of reach of children and pets, as these patches may still contain active drug substances that could lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and effectiveness.

After use, the patch must be disposed of properly to prevent access by children and pets, ensuring safety in the environment.

Additional Clinical Information

The route of administration for the product is topical. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. The patch should be removed after a maximum application time of 8 hours. For children under 12 years of age, consultation with a physician is recommended prior to use.

Clinicians should counsel patients on potential allergic reactions, particularly for those with known sensitivities to aspirin or salicylates. It is important to instruct patients on the safe disposal of used patches to prevent accidental exposure to children and pets, as these patches may still contain active drug that could lead to serious adverse effects if ingested. Additionally, patients should be advised to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the patch is swallowed.

Drug Information (PDF)

This file contains official product information for Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)